AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get workout gear delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Philadelphia Eagles quarterback Jalen Hurts was diagnosed with deep vein thrombosis and blood clots in both lungs after an initial finding of a superficial clot in his left calf. The team says he is taking blood thinners, cannot take part in contact activities and is expected to make a full recovery; no return date has been announced.

Philadelphia Eagles quarterback Jalen Hurts has deep vein thrombosis (DVT) and blood clots in both lungs, according to a report by MedPage Today, citing the team’s account of his diagnosis. The 28-year-old is taking blood thinners and will not take part in contact activities while being treated. The Eagles said they expect him to recover fully, but have not announced when he can return to football.

Hurts was first diagnosed with a superficial vein thrombosis in his left calf after he said he was “cleated” during a game against the Los Angeles Rams in early October. A follow-up ultrasound after an October 11 game found that the clot had moved, MedPage Today reported. Further testing identified DVT and clots in both lungs.

The Eagles said in an Instagram post that Hurts is receiving anticoagulant treatment, commonly called blood thinners, and cannot participate in contact activities. The team described his prognosis as very good and said it anticipates a full recovery with no long-term effects. Those are the team’s expectations; the report does not provide a detailed clinical assessment or a timetable for his return.

Northwell Health pulmonologist Gita Lisker, MD, told MedPage Today that an injury can trigger inflammation that increases clot risk, while genetics can also be a factor. She said it is not clear whether Hurts’s injury caused the clots, whether a superficial clot extended into a deeper vein, or whether different clots were present at the same time.

At a glance
reportWhen: Reported October 20, 2026; diagnosis fo…
The developmentFollow-up testing found DVT and clots in both lungs in Jalen Hurts, who is being treated with blood thinners and barred from contact activities.

Clot Treatment Puts Contact Play On Hold

The diagnosis matters both for Hurts’s health and for the Eagles’ plans. DVT can lead to pulmonary embolism when a clot travels to the lungs, a potentially serious complication. MedPage Today’s report says Hurts has clots in both lungs, making the team’s restriction on contact activity a health precaution, not simply a routine injury decision.

Blood thinners reduce the chance of additional clots and help stabilize existing ones as the body gradually absorbs them. But they also increase the risk of bleeding. As Lisker told MedPage Today, football exposes players to tackles, head impacts and cuts from cleats, making contact play a particular concern during anticoagulant treatment.

The report does not establish how long Hurts will be unavailable or whether the Eagles have set a roster plan around his absence. The immediate confirmed point is that he is not cleared for contact activities. His status will matter to the team’s quarterback decisions, but any projected return date would be speculation until the Eagles provide one.

Amazon

blood thinners for deep vein thrombosis

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

From Calf Clot To Lung Findings

Superficial vein thrombosis affects veins close to the skin and can cause redness, swelling and inflammation. DVT involves deeper veins, most often in the legs. Lisker explained to MedPage Today that a superficial clot may spread into a deep vein, but it is also possible for clots to coexist and for the superficial one to be detected first. The available report does not say which sequence occurred in Hurts’s case.

Clots in the lungs are referred to as pulmonary emboli. Lisker said not every DVT leads to a pulmonary embolism, although many pulmonary embolisms originate from DVT. The report describes Hurts’s lung findings but does not provide details about symptoms, clot size or the specific tests used beyond the follow-up ultrasound and additional testing.

Anticoagulation is standard treatment after DVT and pulmonary embolism, according to Lisker. She said treatment commonly lasts three to six months, depending on a patient’s risk factors. That range is general medical context, not a disclosed treatment plan or confirmed duration for Hurts.

“Jalen’s prognosis is very good, and we expect a full recovery. More importantly, we anticipate that he will have no long-term effects.”

— Philadelphia Eagles, in an Instagram post quoted by MedPage Today

Amazon

anticoagulant medication for blood clots

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Clot Cause And Return Date Unknown

The report does not establish whether the calf injury caused the clots, whether the superficial clot progressed to DVT, or whether the different clots developed separately. Lisker described these as possibilities rather than a confirmed explanation. No detailed information is provided about the lung clots, Hurts’s symptoms, his individual risk factors or his response to treatment.

The Eagles have not given a treatment duration or return-to-play date. The three-to-six-month anticoagulation period discussed by Lisker is a general range and should not be read as Hurts’s prescribed course. The team’s expectation of full recovery is not a medical timeline, and it remains unclear when clinicians might consider him safe to resume football contact.

Amazon

compression stockings for blood circulation

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Medical Clearance Will Guide Return

The immediate next step is continued treatment and follow-up with Hurts’s medical team. He will remain out of contact activities under the restriction reported by the Eagles. Any decision about exercise, training or return to football will depend on his clinical course and medical clearance; the team has not announced a timetable.

Further updates from the Eagles may clarify his progress, the length of treatment and whether he can rejoin football activities in stages. Until then, the confirmed status is limited: Hurts is taking blood thinners, has been barred from contact activity and is expected by the team to recover fully.

Amazon

blood clot recovery support products

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

What blood clot diagnoses were reported for Jalen Hurts?

MedPage Today reported that follow-up testing found deep vein thrombosis and blood clots in both lungs, after Hurts was initially diagnosed with a superficial clot in his left calf.

Is Hurts playing football while taking blood thinners?

No contact activity has been reported as permitted. The Eagles said Hurts is on blood thinners and cannot take part in contact activities, where impacts or cuts could cause dangerous bleeding.

Did his calf injury cause the clots?

That has not been established. Pulmonologist Gita Lisker told MedPage Today that injury-related inflammation could contribute, but said the clots may also have existed at the same time or followed another sequence.

How long will Hurts be out?

The Eagles have not announced a return date or Hurts’s treatment duration. Lisker said anticoagulation often lasts three to six months after an acute clotting incident, depending on risk factors; that general range is not a confirmed plan for Hurts.

What is the team saying about his recovery?

The Eagles said Hurts’s prognosis is very good and that they expect a full recovery with no long-term effects. The team has not provided a timeline for when he might resume contact football.

Source: rss

Wellness content on this site is informational and not a substitute for professional medical guidance.
FALL

Fall Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Gilead Sciences Surges In Global Coverage

Gilead Sciences experiences a notable surge in worldwide media mentions, indicating increased public and industry interest in the biotech firm.

NADclinic And GCLS Agree On Strategic Partnership For Education In Longevity And Performance Medicine

NADclinic and GCLS announce a strategic partnership to expand training in longevity and performance medicine, aiming to enhance industry standards and professional development.

I Used To Think Being Easy To Get Along With Was A Compliment

A Tiny Buddha essay describes how one woman began naming her preferences after realizing that being “easy” had obscured what she wanted.

Elevance Health Surges In Global Coverage

Elevance Health experiences a notable surge in international coverage, marking a major expansion in its global presence and market reach.